Exiqon Diagnostics partners with MedTrust online to promote KRAS mutation analysis and other innovative molecular oncology diagnostic services to oncologists

May 29, 2009

By hammersmith

[Source: PRNewswire] – Exiqon Diagnostics, announced
today a strategic commercial partnership with MedTrust Online, an
innovative, comprehensive internet based solution provider for
oncologists that offers clinically useful knowledge on the latest
topics in cancer treatment. Exiqon Diagnostics, a leader in
individualizing cancer care through novel molecular and cell-based (the Oncotech EDR(R) Assay) clinical laboratory services, will become a content partner by providing a comprehensive suite of oncology molecular diagnostics services to MedTrust Online’s Oncocentric oncology portal.

MedTrust Online will add Exiqon Diagnostics service offerings,
extensive clinical studies, insurance/billing information, order forms, and live forum case studies available to MedTrust’s growing oncology health care provider user base consisting of thousands of medical, gynecologic and surgical oncologists as well as pathologists and support staff nationwide.

For more information click here.